185 related articles for article (PubMed ID: 16982034)
1. Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
Berger F; Unterholzner S; Diebold J; Knesewitsch P; Hahn K; Spitzweg C
Biochem Biophys Res Commun; 2006 Nov; 349(4):1258-63. PubMed ID: 16982034
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue.
Upadhyay G; Singh R; Agarwal G; Mishra SK; Pal L; Pradhan PK; Das BK; Godbole MM
Breast Cancer Res Treat; 2003 Jan; 77(2):157-65. PubMed ID: 12602914
[TBL] [Abstract][Full Text] [Related]
3. The sodium iodide symporter: its pathophysiological and therapeutic implications.
Spitzweg C; Morris JC
Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
[TBL] [Abstract][Full Text] [Related]
4. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
Rai R; Shrivastava A; Tandon A; Godbole MM; Kumar S; Das V; Dwivedi V; Pal L
Indian J Exp Biol; 2011 Feb; 49(2):113-7. PubMed ID: 21428212
[TBL] [Abstract][Full Text] [Related]
5. The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.
Ryan J; Curran CE; Hennessy E; Newell J; Morris JC; Kerin MJ; Dwyer RM
PLoS One; 2011 Jan; 6(1):e16023. PubMed ID: 21283523
[TBL] [Abstract][Full Text] [Related]
6. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer.
Kilbane MT; Ajjan RA; Weetman AP; Dwyer R; McDermott EW; O'Higgins NJ; Smyth PP
J Clin Endocrinol Metab; 2000 Mar; 85(3):1245-50. PubMed ID: 10720070
[TBL] [Abstract][Full Text] [Related]
7. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
8. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
9. [The practical relevance of the sodium iodide symporter].
Spitzweg C
Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
[TBL] [Abstract][Full Text] [Related]
10. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
Unterholzner S; Willhauck MJ; Cengic N; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2006 Jan; 91(1):69-78. PubMed ID: 16234306
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
14. PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer.
Knostman KA; McCubrey JA; Morrison CD; Zhang Z; Capen CC; Jhiang SM
BMC Cancer; 2007 Jul; 7():137. PubMed ID: 17651485
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.
Wapnir IL; van de Rijn M; Nowels K; Amenta PS; Walton K; Montgomery K; Greco RS; Dohán O; Carrasco N
J Clin Endocrinol Metab; 2003 Apr; 88(4):1880-8. PubMed ID: 12679487
[TBL] [Abstract][Full Text] [Related]
16. The mammary gland iodide transporter is expressed during lactation and in breast cancer.
Tazebay UH; Wapnir IL; Levy O; Dohan O; Zuckier LS; Zhao QH; Deng HF; Amenta PS; Fineberg S; Pestell RG; Carrasco N
Nat Med; 2000 Aug; 6(8):871-8. PubMed ID: 10932223
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
[TBL] [Abstract][Full Text] [Related]
18. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
[TBL] [Abstract][Full Text] [Related]
20. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
